Carolyn J Sympson

Title: The Innovations of Carolyn J. Sympson

Introduction

Carolyn J. Sympson is a notable inventor based in Ballwin, MO (US). She has made significant contributions to the field of biochemistry, particularly through her work on methionine aminopeptidases. Her research has implications for understanding protein synthesis and enzyme activity.

Latest Patents

Sympson holds a patent for a newly-discovered enzyme known as methionine aminopeptidase type-3 (MetAP-3). This enzyme plays a crucial role in the co-translational removal of amino terminal methionine residues from nascent polypeptide chains. Unlike its counterparts, MetAP-1 and MetAP-2, MetAP-3 is not inhibited by fumagillin, an irreversible inhibitor of MetAP-2. Additionally, MetAP-3 preferentially localizes to mitochondria, which distinguishes it from MetAP-1 and MetAP-2 that accumulate in the cytoplasm. Her patent also encompasses human cDNAs encoding polypeptides comprising MetAP-3, as well as nucleic acid molecules derived from these cDNAs.

Career Highlights

Sympson has worked at Pharmacia Corporation, where she has been able to apply her expertise in enzyme research. Her work has contributed to advancements in the understanding of enzyme specificity and localization, which are critical for various biological processes.

Collaborations

Throughout her career, Sympson has collaborated with notable colleagues such as Rajeev Aurora and Stanton B. Dotson. These collaborations have likely enriched her research and contributed to the successful development of her patented innovations.

Conclusion

Carolyn J. Sympson's work on methionine aminopeptidase type-3 represents a significant advancement in biochemistry. Her contributions continue to influence the field and pave the way for future research and applications.